Tag: Health care industry
Amgen starts two critical late-stage trials for weight loss drug MariTide
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023.Mario Tama | Getty ImagesAmgen on Wednesday said...
Novo Nordisk offers Wegovy for less than half the price through...
Novo Nordisk's Wegovy weight loss drug has seen a meteoric rise in popularity. Nurphoto | Getty ImagesNovo Nordisk on Wednesday said it will offer...
Kenvue settles proxy fight with activist Starboard, adding three directors to...
Kenvue settled its proxy fight with activist Starboard Value, adding three new directors to its board.Starboard's Jeff Smith will join the board of...
FDA cancels vaccine advisory meeting for choosing flu strains for next...
FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009. Jason Reed |...
Eli Lilly plans at least $27 billion in new U.S. manufacturing...
Eli Lilly on Wednesday said it will invest at least $27 billion to build four new manufacturing sites in the U.S., as demand...
Shortage of Novo Nordisk’s Wegovy and Ozempic drugs is resolved, FDA...
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy.Hollie Adams | ReutersThe long-running U.S. shortage of Novo Nordisk's...
UnitedHealth’s rough stretch continues, with buyouts, a reported DOJ probe and...
FILE PHOTO: The logo of Down Jones Industrial Average stock market index listed company UnitedHealthcare is shown in Cypress, California April 13, 2016. Mike...
Once high-flying Bluebird Bio sells itself to private equity after tough...
Sopa Images | Lightrocket | Getty ImagesBluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million,...
Hims & Hers to offer at-home blood draws, lean into ‘peptide...
The New York Stock Exchange with a Hims & Hers Health banner is pictured in the Manhattan borough of New York City.Carlo Allegri...
From pills to new uses, here’s what Eli Lilly’s top scientist...
Dan Skovronsky knows what makes a good obesity drug.As chief scientific officer at Eli Lilly, he's already done it once with the company's...
